Members of the EBM Focus editorial team at DynaMed® select their top clinical trial summaries of 2019.
EBM Focus: 2019 Year in Review
January 14, 2020
A new 20-year follow-up study suggests that long-term statin therapy starting in childhood may prevent cardiovascular disease in patients with familial hypercholesterolemia.
EBM Focus: Statin’ Young– Benefit of Starting Statins in Children with Familial Hypercholesterolemia
January 07, 2020
A new study fails to confirm efficacy of 17-P for prevention of preterm birth in women with prior preterm birth, but will this change standard of care?
EBM Focus: “Confirmatory Trial” Creates Uncertainty about 17-P for Prevention of Premature Birth
December 17, 2019
Read about new meta-analyses aiming to address whether consumption of red or processed meat is truly bad for cardiovascular health.
EBM Focus: Holy Cow! Reheating the Debate on Eating Red Meat
December 03, 2019
Personalized risk-based colorectal cancer screening would be ideal, but we may not yet be ready for such an approach. Find out why in this EBM Focus.
EBM Focus: A Protoscopy of the New Colorectal Cancer Screening Guideline
November 14, 2019
A new study evaluates personalized stratification of the net benefit or harm of aspirin for primary prevention of cardiovascular disease (CVD).
EBM Focus: PREDICTing the Net Benefit of Aspirin for Primary Prevention
November 12, 2019
Point-of-care C-reactive protein (CRP) testing may allow for more judicious use of antibiotics in patients with an acute COPD exacerbation.
EBM Focus: CRP-guided Antibiotic Therapy for Acute Exacerbations of COPD
November 06, 2019
Read about a new trial showing noninferiority of oral semaglutide for cardiovascular outcomes in patients with type 2 diabetes.
EBM Focus: Oral Semaglutide May Be Safe for Those at High Cardiovascular Risk
November 04, 2019
Driving low density lipoprotein cholesterol (LDL-C) as low as possible seems to be the mindset of many clinicians and patients these days. But how low is too low?
EBM Focus: Low LDL Cholesterol May Be Associated with Intracerebral Hemorrhage
September 30, 2019
Two new studies investigate shorter duration of DAPT after stent placement in patients at low-intermediate risk of bleeding. Read more in the latest EBM Focus.
EBM Focus: Don’t overDAPT it – One Month May Be Enough After Stent Placement for Low-Risk Patients
August 29, 2019
© 2020 EBSCO Industries, Inc. All rights reserved